首页> 美国卫生研究院文献>Drug Design Development and Therapy >Dexmedetomidine for awake intubation and an opioid-free general anesthesia in a superobese patient with suspected difficult intubation
【2h】

Dexmedetomidine for awake intubation and an opioid-free general anesthesia in a superobese patient with suspected difficult intubation

机译:右美托咪定用于疑似插管困难的超肥胖患者的清醒插管和无阿片类药物的全身麻醉

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Super-obese patients (body mass index [BMI] >50 kg/m2) are at a particularly high risk of anesthesia-related complications during postoperative period, eg, critical respiratory events including respiratory arrest, and over-sedation leading to problems with maintaining airway open, hypoxia and hypercapnia. In this paper authors present a case of a 39-year-old super-obese (BMI 62.3 kg/m2) female patient who was admitted for surgical treatment of obesity. Preanesthesia evaluation revealed hypertension and type 2 diabetes mellitus (DM) as comorbidities as well as potential for a difficult intubation– neck circumference of 46 cm, reduced neck mobility and DM type 2. Patient was intubated using “awake intubation” method using topical anesthesia and dexmedetomidine infusion. General anesthesia was maintained with sevoflurane and dexmedetomidine infusion instead of opioid administration in “opioid-free anesthesia method”.
机译:超肥胖患者(体重指数[BMI]> 50 kg / m 2 )在手术期间处于与麻醉相关的并发症的特别高的风险,例如,严重的呼吸道疾病,包括呼吸骤停和过度镇静会导致气道开放,缺氧和高碳酸血症。本文作者介绍了一位39岁的超肥胖(BMI 62.3 kg / m 2 )女性患者,该患者接受了外科手术治疗肥胖。麻醉前评估显示高血压和2型糖尿病(DM)合并症以及潜在的插管困难–颈围为46 cm,颈部活动度降低和DM 2型。使用局部麻醉和“清醒插管”方法对患者进行插管右美托咪定输注。使用七氟醚和右美托咪定输注维持全身麻醉,而不是在“无阿片类药物麻醉方法”中给予阿片类药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号